Compliance Rate

Compliance Rate 51.23%
Compliant submissions 187
Incompliant submissions 178
Total trials 365

My Organizations' Clinical Trials

Showing 300 of 2400 entries
View as:

Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide

Phase: N/A Priority: Normal
NCT ID: NCT03910452 Org: User:
Start: 10/28/19 End: 06/15/34 Due: 06/15/35

Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00528489 Org: User:
Start: 10/31/07 End: 01/31/10 Due: 01/31/11

A Collaborative Double-Blind Placebo-Controlled Trial of Intravenous Ribavirin As a Treatment for Presumed Hantavirus Pulmonary Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00001123 Org: User:
Start: - End: 11/30/05 Due: 11/30/06

Prevention of Kidney Transplant Rejection

Phase: N/A Priority: Normal
NCT ID: NCT00005010 Org: User:
Start: - End: 03/31/04 Due: 03/31/05

Assessment of Pre-Exposure Prophylaxis (PrEP) Administered at Sexually Transmitted Disease (STD) Clinics

Phase: N/A Priority: Normal
NCT ID: NCT01632995 Org: User:
Start: 10/31/12 End: 02/28/15 Due: 02/28/16

Evaluating the Safety and Immune Response of an Adenovirus-Based HIV Vaccine in HIV-Uninfected Adults

Phase: N/A Priority: Normal
NCT ID: NCT01103687 Org: User:
Start: 07/31/10 End: 05/31/16 Due: 05/31/17

Controlling Acute or Early HIV Infection With Antiretroviral Drugs, Without a Candidate Vaccine.As Reported Previously, the Candidate Vaccie Was Not Provided by the Maufacturer as Promised

Phase: N/A Priority: Normal
NCT ID: NCT00238459 Org: User:
Start: 07/31/05 End: 10/31/13 Due: 10/31/14

Haploidentical Transplant for People With Chronic Granulomatous Disease Using Post Transplant Cyclophosphamide

Phase: N/A Priority: Normal
NCT ID: NCT02282904 Org: User:
Start: 10/23/14 End: 12/10/19 Due: 12/10/20

Evaluating the Safety of and Immune Response to a Dengue Vaccine (TV003) in Healthy Adults, Adolescents, and Children in Thailand

Phase: N/A Priority: Normal
NCT ID: NCT02332733 Org: User:
Start: 11/30/14 End: 10/26/18 Due: 10/26/19

A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin (KLH)

Phase: N/A Priority: Normal
NCT ID: NCT01489956 Org: User:
Start: 12/31/11 End: 04/30/13 Due: 04/30/14

Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in HIV

Phase: N/A Priority: Normal
NCT ID: NCT00084149 Org: User:
Start: 02/29/04 End: 01/31/08 Due: 01/31/09

Safety of and Immune Response to an Adenoviral HIV-1 Vaccine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00618605 Org: User:
Start: 02/29/08 End: 10/31/15 Due: 10/31/16

Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®

Phase: N/A Priority: Normal
NCT ID: NCT01827371 Org: User:
Start: 06/30/13 End: 04/30/15 Due: 04/30/16

Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT01443663 Org: User:
Start: 10/31/11 End: 03/31/13 Due: 03/31/14

LEA29Y (Belatacept) Emory Edmonton Protocol

Phase: N/A Priority: Normal
NCT ID: NCT00468403 Org: User:
Start: 10/31/08 End: 04/30/13 Due: 04/30/14

A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes

Phase: N/A Priority: Normal
NCT ID: NCT00076232 Org: User:
Start: 04/30/05 End: 11/30/07 Due: 11/30/08

Combination Pain Therapy in HIV Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT00863057 Org: User:
Start: 05/31/09 End: 12/31/10 Due: 12/31/11

Effect of Bismuth Subsalicylate on the Gut Microbiome and Host Response in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05930197 Org: User:
Start: 08/31/23 End: 12/15/24 Due: 12/15/25

Seasonal Influenza DNA Vaccine & Seasonal Influenza Trivalent Inactivated Vaccine (TIV) in Children & Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT01609998 Org: User:
Start: 06/30/12 End: 07/31/13 Due: 07/31/14

gB/MF59 Vaccine in Preventing Cytomegalovirus Infection in Healthy Adolescent Females

Phase: N/A Priority: Normal
NCT ID: NCT00133497 Org: User:
Start: 06/30/06 End: 06/30/13 Due: 06/30/14

Anti-malaria MAb in Kenyan Children

Phase: N/A Priority: Normal
NCT ID: NCT05400655 Org: User:
Start: 09/14/22 End: 06/02/24 Due: 06/02/25

Immunogenicity and Safety Study of Inactivated Subunit H5N1 Influenza Vaccine in Prior Recipients of Live Attenuated H2N2, H6N1 and H9N2 Influenza Vaccines and in H5N1 and Live Attenuated Vaccine Naïve Individuals

Phase: N/A Priority: Normal
NCT ID: NCT03816878 Org: User:
Start: 01/08/19 End: 03/17/20 Due: 03/17/21

Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02101138 Org: User:
Start: 03/14/14 End: 10/23/19 Due: 10/23/20

Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00240994 Org: User:
Start: 01/31/05 End: 11/30/09 Due: 11/30/10

Immune and Viral Status of HIV-Infected Patients After Stopping Combination Antiretroviral Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00001899 Org: User:
Start: 12/16/98 End: 04/08/13 Due: 04/08/14